Clinical case of the combined antithrombotic therapy in case of acute coronary syndrome with atrial fibrillation

The comorbidity of atrial fibrillation (AF) and acute coronary syndrome (ACS) often occurs in clinical practice. The treatment of ACS prescribes double antiplatelet therapy (DAT). The presence of AF makes it necessary to prevent thromboembolic complications (FS) through the appointment of oral anticoagulants (UAC). In the presence of simultaneous indications for taking antiplatelet agents and oral anticoagulant, it is necessary to choose the optimal combination. The number of antiplatelet agentsand oral anticoagulants has recently expanded significantly, the results of studies on the antithrombotic efficacy and safety of new oral anticoagulants in patients with AF, different combinations of antiplatelet agents in dual antiplatelet therapy (DAP) in ACS, different combinations of antiplatelet agents and anticoagulants in ACS in a patient with AF have been published. In each clinical case of combined pathology of ACS and AF, the doctor has to implement a personalized approach when prescribing combined AAT.